RICHMOND, Va., Feb. 29,
2024 /PRNewswire/ -- Indivior PLC (LSE: INDV; Nasdaq:
INDV), a leading addiction treatment company, today announced that
its subsidiary, Indivior Inc., has received final Court approval
for its settlement with the Direct Purchaser class, concluding the
anti-trust multi-district litigation ("MDL") matter.
On October 22, 2023, Indivior Inc.
entered into a settlement agreement with the remaining Direct
Purchaser class for $385m. On
February 27, 2024, the United States District Court for the
Eastern District of Pennsylvania
entered an order granting final judgement and order of dismissal
approving the Direct Purchaser class settlement and dismissing the
Direct Purchaser class claims. This ruling concludes the Antitrust
MDL.
About Indivior
Indivior is a global pharmaceutical
company working to help change patients' lives by developing
medicines to treat addiction and serious mental illnesses. Our
vision is that all patients around the world will have access to
evidence-based treatment for the chronic conditions and
co-occurring disorders of substance use disorder (SUD). Indivior is
dedicated to transforming SUD from a global human crisis to a
recognized and treated chronic disease. Building on its global
portfolio of OUD treatments, Indivior has a pipeline of product
candidates designed to both expand on its heritage in this category
and potentially address other chronic conditions and co-occurring
disorders of SUD, including alcohol use disorder and cannabis use
disorder. Headquartered in the United States in Richmond, VA,
Indivior employs more than 1,100 individuals globally and its
portfolio of products is available in 37 countries worldwide.
Visit www.indivior.com to learn more. Connect with Indivior on
LinkedIn by visiting www.linkedin.com/company/indivior.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/court-provides-final-approval-of-settlement-with-direct-purchaser-class-in-the-multidistrict-antitrust-litigation-final-court-approval-concludes-the-antitrust-multidistrict-litigation-302075022.html
SOURCE Indivior PLC